Application | Comment | Organism |
---|---|---|
medicine | ADAM15 ranks in the top 5% of amplified genes and its mRNA is significantly overexpressed in invasive and metastatic bladder cancer compared to noninvasive disease. In metastatic samples, increased ADAM15 immunoreactivity is associated with increasing cancer stage and exhibits significantly stronger staining. The knockdown of ADAM15 mRNA expression significantly inhibits bladder tumor cell migration and reduces the invasive capacity of bladder tumor cells through MatrigelTM and monolayers of vascular endothelium. The knockdown of ADAM15 in a human xenograft model of bladder cancer inhibits tumor growth by 45% compared to controls | Homo sapiens |
Inhibitors | Comment | Organism | Structure |
---|---|---|---|
adamastat | sulfonamide inhibitor, binds to the active site of the ADAM15 metalloproteinase domain with a calculated binding energy of -9.0 kcal/mol.In the preferred binding mode, the biphenyl amino side chain of the inhibitor resides in the deep amphipathic S1' amino acid recognition pocket of the ADAM15 catalytic domain. Adamastat significantly inhibits the viability of UM-UC-9 and UM-UC-6 cells at 10 microM | Homo sapiens |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Homo sapiens | - |
- |
- |
Source Tissue | Comment | Organism | Textmining |
---|---|---|---|
bladder | - |
Homo sapiens | - |
carcinoma cell | - |
Homo sapiens | - |
Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|
dabcyl-HGDQMAQKSK(5FAM)-NH2 + H2O | - |
Homo sapiens | ? | - |
? |